Cefaléias em salvas: estudo das alterações autonômicas e outras manifestações associadas em 28 casos Cluster headache: study of autonomic alterations and other associated manifestations in 28 cases

As cefaléias de curta duração dividem-se entre aquelas com pouca ativação; autonômica e aquelas com importante ativação, este grupo inclui a cefaléia em salvas. Este trabalho tem por objetivo discutir a fisiopatologia da cefaléia em salvas, com maior enfoque nos fenômenos autonômicos, como injeção conjuntival, lacrimejamento, congestão nasal, rinorréia, semiptose e edema palpebral, mostrando o nítido envolvimento do núcleo salivatório superior com a propagação do estímulo doloroso, originado no nervo trigêmeo. As alterações autonômicas foram estudadas em 28 pacientes com cefaléia em salvas e as prevalentes foram o lacrimejamento e a hiperemia conjuntival.<br>The short lasting primary headaches are classified as those without autonomic activation and those with important activation, which includes the cluster headache. This study focuses on the pathophysiology of cluster headache mainly in its autonomic phenomenon (conjuntival injection, lacrimation, nasal congestion, rhinorrhoea, parcial ptosis and eyelid oedema) showing the involvement of superior salivatory nucleus with the pain stimulus propagation, which begins in the trigeminal nerve. The autonomic alterations were studied in 28 patients being lacrimation and conjuntival injection, the main features

英国における仲裁教育 : School of International Arbitration, Centre for Commercial Law Studies, Queen Mary, University of Londonにおける経験から

Prednisolone and other glucocorticoids (GCs) are potent anti-inflammatory drugs, but chronic use is hampered by metabolic side effects. Therefore, there is an urgent medical need for improved GCs that are as effective as classical GCs but have a better safety profile. A well-established model to assess anti-inflammatory efficacy is the chronic collagen-induced arthritis (CIA) model in mice, a model with features resembling rheumatoid arthritis. Models to quantify undesired effects of glucocorticoids on glucose kinetics are less well-established. Recently, we have described a model to quantify basal blood glucose kinetics using stably-labeled glucose. In the present study, we have integrated this blood glucose kinetic model in the CIA model to enable quantification of both efficacy and adverse effects in one animal model. Arthritis scores were decreased after treatment with prednisolone, confirming the anti-inflammatory properties of GCs. Both inflammation and prednisolone induced insulin resistance as insulin secretion was strongly increased whereas blood glucose concentrations and hepatic glucose production were only slightly decreased. This insulin resistance did not directly resulted in hyperglycemia, indicating a highly adaptive compensatory mechanism in these mice. In conclusion, this 'all-in-one' model allows for studying effects of (novel) GC compounds on the development of arthritis and glucose kinetics in a single animal. This integrative model provides a valuable tool for investigating (drug-induced) metabolic dysregulation in an inflammatory setting